Acesion Pharma

Acesion Pharma is a Danish biotechnology company headquartered in Copenhagen, Denmark. The company’s medical drug development for treating atrial fibrillation, the most common type of arrhythmia, is based on the concept of inhibiting an ion channel involved in generating the electrical signals that regulate heart rhythm in cardiac cells, enabling consumers of chronic treatments to prevent AF recurrence and maintain normal heart rhythm.